The 7-year intracranial progression free-survival among patients treated with combination therapy was 42%.
Melanoma News
Surviving melanoma has a new genetic story
Australia has the highest incidence of melanoma in the world with one Aussie diagnosed every 30 minutes.1 Delve into the research led by Dr Sarah Ward aiming to unpack the genetic epidemiology of melanoma.
Smart Nanotherapy Enhances Immune Attack on Melanoma
Recently, Prof. WU Zhengyan from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, in collaboration with Prof. ZHANG Guilong from Binzhou Medical University, has developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.
FDA Clears IND Application for CER-1236 in Advanced Solid Tumors
A second phase 1 trial plans to evaluate CER-1236, a novel chimeric antigen receptor therapy, for solid tumors.